September 01, 2021

Looking Ahead to Factors Shaping Market Activity

A bylined article exploring the factors shaping M&A activity in the life sciences sector by EMEA CRO Merlin Piscitelli was published in the September issue of Pharmaceutical Technology Europe. The article highlights how the sector continues to attract investor interest despite unprecedented disruption caused by the pandemic. 

Contacts

Media Relations
Marta Carraro

Vice President, Communications

212.367.6162

[email protected]

Investor Relations
Jennifer Percy

Senior Vice President, Finance & Treasury

651.632.4009

[email protected]

You may also like:

Dealmakers Ready to Reignite M&A Push This Year, Survey Finds

EMEA CRO Merlin Piscitelli discusses findings from Datasite's 2H22 Dealmaker survey about UK M&A professionals' optimism on deal volumes for the next 12 months.

City AM logo
Though Not as Frenzied as Last Year, M&A Remains Strong

CEO Rusty Wiley shares insights on the current state of M&A. While not as frenzied as last year, global dealmaking remains strong.

Forbes
HR Works Presents HR Work Break: Listening Is the First Step in Allyship

CHRO Deb LaMere discusses how to build a culture of diversity, equity, and inclusion, citing findings from Datasite's Talent and Diversity in M&A survey.